Neuro-fuzzy classification of asthma and chronic obstructive pulmonary disease by unknown
RESEARCH ARTICLE Open Access
Neuro-fuzzy classification of asthma and chronic
obstructive pulmonary disease
Almir Badnjevic1*†, Mario Cifrek1†, Dragan Koruga2†, Dinko Osmankovic3†
Abstract
Background: This paper presents a system for classification of asthma and chronic obstructive pulmonary disease
(COPD) based on fuzzy rules and the trained neural network.
Methods: Fuzzy rules and neural network parameters are defined according to Global Initiative for Asthma (GINA)
and Global Initiative for chronic Obstructive Lung Disease (GOLD) guidelines. For neural network training more
than one thousand medical reports obtained from database of the company CareFusion were used. Afterwards the
system was validated on 455 patients by physicians from the Clinical Centre University of Sarajevo.
Results: Out of 170 patients with asthma, 99.41% of patients were correctly classified. In addition, 99.19% of the
248 COPD patients were correctly classified. The system was 100% successful on 37 patients with normal lung
function. Sensitivity of 99.28% and specificity of 100% in asthma and COPD classification were obtained.
Conclusion: Our neuro-fuzzy system for classification of asthma and COPD uses a combination of spirometry and
Impulse Oscillometry System (IOS) test results, which in the very beginning enables more accurate classification.
Additionally, using bronchodilatation and bronhoprovocation tests we get a complete patient’s dynamic
assessment, as opposed to the solution that provides a static assessment of the patient.
Background
Asthma is an inflammatory impairment of airways, which
as result becomes hyperreactive and generates increased
mucus, mucosal swelling and contraction of smooth air-
way muscles, all of which contribute to airway obstruction.
In addition, the prevalence of asthma has been increasing
in the recent decades, as well as the costs for asthma care
[1-3]. One of the problems related to asthma management
is that a number of patients with asthma are either impro-
perly diagnosed or misdiagnosed for having other respira-
tory diseases such as a common cold, acute bronchitis or
chronic obstructive pulmonary disease (COPD) [4,5].
COPD is a respiratory disorder characterized by chronic
and recurrent airflow obstruction, which increases resis-
tance and dynamic hyperinflation of the peripheral airways
[6,7]. The two main examples of this are obstructive
emphysema and chronic bronchitis. Approximately 75% of
all COPD patients do not have diagnosis. Most of them
have a mild degree COPD, but among them a 4% are with
severe degree and 1% with very severe degree of COPD
[8]. Approximately 200,000 to 300,000 people in Europe
die every year due to COPD, and the number exceeds the
quote of lung cancer and breast cancer together [9-11].
Based on presented diagnosis problems there is a need
for the system which can help physicians to make more
successful diagnosis.
The most commonly used pulmonary function tests
that are used to detect asthma and COPD are spirometry
and Impulse Oscillometry System (IOS) [12,13]. Neuro-
fuzzy systems are used for the detection different types of
diseases. In 2004, Barua et al [14] presented a system
based on trained neural networks that uses the results of
measurements performed by IOS for classification of
asthma. In 2009, Winkler et al [15] were able to diagnose
asthma and COPD patients using different measurement
methods on IOS. Asaithambi et al [16] in 2012 made
classification of respiratory abnormalities using adaptive
neuro fuzzy inference system based only on spirometric
measurements. As can be seen from the papers [14-16]
the authors have tried to using their neuro fuzzy systems
to perform diagnosis of disease based on the results of
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lung function measurements using only IOS or spirome-
try. In 2008, Meraz et al [17] designed software for clas-
sification of respiratory disease in children. The same
year Hafezi [18] made an integrated software package
for model-based neuro-fuzzy classification of small air-
way dysfunction, based on augmented RIC (aRIC)
and extended RIC (eRIC) equivalent lung models and
IOS data.
The most successful diagnosis is achieved in combina-
tion of IOS and spirometry measuring test results [6-9].
Based on it a static assessment of the patient is obtained,
which is achieved only on symptoms and first pulmonary
function testing, without any further monitoring of
patients. In order to get dynamic assessment of the
patient, it is necessary to take the patient’s symptoms and
allergies in consideration, to perform auscultation of the
patient, and to apply bronchial dilation (BDT) and bron-
chial provocation tests (BPT). After BDT and/or BPT
treatment and after the second and/or third measurement
of lung function, potential changes of pulmonary para-
meter values may be presented, from which physicians get
accurate information on the specifics of the disease.
Dynamic assessment of the patient is necessary process
according to Global Initiative for Asthma (GINA) and
Global Initiative for chronic Obstructive Lung Disease
(GOLD) guidelines [19,20].
This paper presents a neuro-fuzzy system for classifi-




Neuro-fuzzy system architecture for asthma and COPD
classification is presented in Figure 1.
Input data for our fuzzy rules are results from .pdf files
obtained from spirometry (SPIR) and IOS measurement
reports. Those data are used to preliminary perform clas-
sification of diseases, and they present input vector of the
neural network. Symptoms based on GINA and GOLD
guidelines and ANN classification results gives proposed
diagnosis.
Asthma was defined based on history of recurrent
wheezing, cough, chest tightness or shortness of breath,
in accordance to allergic symptoms, which could have a
seasonal pattern or might exacerbate at night or by com-
mon exposure to allergen, exercise or smoking. Patients
with positive symptoms and Resistance at 5 Hz (R5)
>150%pred, Resistance at 20 Hz (R20)>150%pred, Reac-
tance at 5 Hz (X5pred - X5)>0.15 kPa/(L/s), Ratio of
Forced Expiratory Volume in 1 second and Forced Vital
Capacity (FEV1/FVC)<0.8 were diagnosed with asthma.
Patients with nonspecific test results were dedicated for
bronchial hyper reactivity (BHR), first with BDT, and
then with BPT. Patients are diagnosed with asthma when
their R5 decreases by more than 25% (ΔR5), the absolute
value of X5 decreases by more than 20% (ΔX5) and FEV1
decreases by more than 12% of baseline value and 200
ml. In cases where BDT did not achieve any improve-
ment for final diagnose, patients were examined with
methacholine BPT. The doses of methacholine, serially
increased, were administered, and FEV1 was measured
after each methacholine dose until a 20% decrease in
FEV1. After this procedure, the system was able to make
the final classification of asthma.
COPD was diagnosed based on positive history of dys-
pnea (progressive, exertion or persistent), chronic cough
(intermittent or non-productive), chronic sputum and a
history of exposure to tobacco, occupational dusts,
Figure 1 Architecture for asthma and COPD classification.
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chemicals or other smokes at an age above 40. The
diagnosis of COPD was confirmed by having a positive
history, R5>150%pred, (X5pred - X5)>0.15 and FEV1/
FVC<0.7. Patients with nonspecific test results were
evaluated for bronchial hyperreactivity (BHR) by means
of BDT, in order to check which group of COPD they
belonged to (A, B, C or D) [19]. The bronchial dilation
test was performed according to international guidelines
using 400 μg of salbutamol. After the completion of the
test, the system was able to make the final classification
of COPD.
Fuzzy logic design
Developed fuzzy systems have been designed according
to experience of other researchers [21-24] and instruc-
tions of GINA and GOLD guidelines.
Input variables for implemented fuzzy system for the
case of IOS are values of R5, R20 and X5 which are
obtained from IOS test report, after pulmonary function
testing’s. Their fuzzy values are defined by the equations
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where: μnormal(R5) is membership function of reference
values of R5 from IOS, μhigh(R5) is membership function
of upper limit of normal (ULN) values of R5 from IOS,
μnormal(X5) is membership function of reference values of
X5 from IOS, μhigh(X5) is membership function of upper
limit of normal values of X5 from IOS, μnone(ΔR) mem-
bership function for none difference between R5 and R20,
μmin(ΔR) is membership function for minimum difference
between R5 and R20 and μsig(ΔR) is membership function
for significant difference between R5 and R20. Fuzzy
values for R20 are the same as for R5. Input values can be
calculated by using fuzzy T-norm operator [25].
Based on the following rules, we can define outputs for
the diagnosis that can be classified by using IOS report:
1. if (R5 is normal) and (R20 is normal) and (R5-R20 is
none) and (X5 is normal) then (output1 is NSCO-SV);
2. if (R5 is normal) and (R20 is normal) and (R5-R20
is minimum) and (X5 is normal) then (output1 is
NSCO-DV);
3. if (R5 is normal) and (R20 is normal) and (R5-R20 is
significant) and (X5 is normal) then (output1 is NSPO);
4. if (R5 is ULN) and (R20 is ULN) and (R5-R20 is
none) and (X5 is normal) then (output1 is CO-SV);
5. if (R5 is ULN) and (R20 is ULN) and (R5-R20 is
minimum) or (X5 is normal) or (X5 is ULN) then
(output1 is CO-DV);
6. if (R5 is ULN) and (R20 is ULN) and (R5-R20 is
significant) and (X5 is ULN) then (output1 is PO);
where NSCO-SV is Negative Sub Central Obstruction
- Same Values, NSCO-DV is Negative Sub Central
Obstruction - Different Values, NSPO is Negative Sub
Peripheral Obstruction, CO-SV is Central Obstruction -
Same Values, CO-DV is Central Obstruction - Different
Values, PO is Peripheral Obstruction, while output1 is
suggestion of classification based on IOS test report.
Artificial neural network design
The results of the analysis and classification based on
the reports of IOS and spirometry are the input vector
of the neural network (NN). Detailed data flow for this
architecture is presented in Figure 2.
The linear feed forward (FF) neural network is,
according to the application experts, sufficient to prop-
erly perform the classification and these types of NN are
mostly used for classification task [26-30]. The network
is divided into layers. The input layer consists only of
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network inputs. It is then followed by a hidden layer
which consists of a number of neurons, or hidden units
placed in parallel. Each neuron performs a weighted
summation of the inputs, which is then passed to some
non-linear activation function s, also called the neuron
function.
In our case, we choose tansig activation function for
hidden layer which is equivalent to the hyperbolic tan-
gent function. This function is used in highly non-linear
data classification [31] which is true in our case.
The network output is formed by another weighted
summation of the outputs of the neurons in the hidden
layer. This summation on the output is called the output
layer. Generally, the number of output neurons equals the
number of outputs of the approximation problem. We
choose linear activation function for the output layer,
because that is commonly used in regression problems
[32].
Artificial neural network (ANN) is trained using esti-
mation data and validated using validation data. We
used 80-20 division to get estimation and validation
data from the data set. The training data set contains
1000 tests previously obtained from database of the
company CareFusion, 800 of them were used for
estimation, and other 200 for validation. The training
algorithm we used is Levenberg-Marquardt (LMA),




We included 455 patients in charge of the Clinic for lung
diseases at Clinical Centre University of Sarajevo, Bosnia
and Herzegovina to test our system of classification of
asthma and COPD. Subjects were separated into two
groups, healthy and diseased. Diseased subjects were
separated into two subgroups, asthmatics and COPD
patients. Out of 455 patients, 170 were asthmatics, 248
were COPD, while 37 patients were healthy subjects.
Basic information about patients involved in the study
are presented in table 1.
Before we began with our study and research we
obtained ethics board approval for human subject from
Clinical Centre University of Sarajevo. All the volunteers
gave written informed consent.
Procedure
For purpose of this study, baseline assessment for all
patients was to answer on questions regarding symptoms,
Figure 2 Data flow of the presented architecture.
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allergies, history and risk factors of asthma and COPD
according to GINA and GOLD guidelines to physicians.
In another step, lung function was measured incorporat-
ing spirometry and IOS test results. All pulmonary function
test reports were obtained using the CareFusion Germany
“Master Screen IOS” device, which allows performing
spirometric and impulse oscillometric lung function tests.
Using spirometry, forced vital capacity (FVC) and
forced expiratory volume in one second FEV1 were
derived, while the ratio FEV1/FVC was calculated. The
impulse oscillometry system (IOS) provided respiratory
resistance R5 at 5 Hz, proximal resistance R20 at 20 Hz,
lung reactance X5 at 5 Hz and resonant frequency Fres
[34,35]. All measured results were compared to pre-
dicted (pred) values of the patient.
If the patients are with nonspecific test results then it
is necessary to do BDT and/or BPT. The bronchial dila-
tion test was performed according to international
guidelines [36,37] using 400 μg of salbutamol. In cases
where BDT did not achieve any improvement for final
diagnose, patients were examined with methacholine
BPT. After this procedure, the neuro-fuzzy system will




Training algorithm for our ANN was Levenberg-Mar-
quardt and it is trained and validated using estimation
and validation data. The training data set contained
1000 tests, 800 of them were used for estimation, and
other 200 for validation, which is presented in Table 2.
In the table 3 are presented the results of testing
recurrent NN architecture with no visible improvement
in classification, but with lower time and memory per-
formance. These results are obtained using Matlab tool
Profiler.
System validation results
Our system is validated on 455 patients. Percentages of
hits and misses of the neuro-fuzzy system in classifica-
tion of asthmatics, COPD and healthy patients involved
in this study are presented in table 4.
Results of neuro-fuzzy system at every step of classifica-
tion in asthmatic and COPD patients are presented in
Figure 3. Due to possibility of obtaining particular results
for static and dynamic assessment of the patient, each step
of neuro-fuzzy system classification is presented. This way
of multiple steps created the possibility to compare our
Table 1 Basic information about patients involved in this study.
Category No. Age (X±SD) Gender Other diseases Smoking Allergies Medications
M F Yes No Yes No Yes No Yes No




























































Table 2 Estimation and validation data for NN.
Number of reports 1000
Estimation set size 800
Validation set size 200
ESTIMATION SET
No. of reports True diagnosis False diagnosis % of true diagnosis
Asthma 350 348 2 99.43%
COPD 350 349 1 99.71%
Healthy 100 100 0 100%
Average: 99.71%
VALIDATION SET
No. of reports True diagnosis False diagnosis % of true diagnosis
Asthma 74 72 2 97.30%
COPD 75 74 1 98.67%
Healthy 51 51 0 100%
Average: 98.65%
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results with the results of other authors who have used
only a static assessment of the patient during diagnosis of
respiratory diseases.
As seen in Table 4 and Figure 3, the neuro-fuzzy sys-
tem performed correct classification of disease for 452
participants, while for 3 participants performed incorrect
classification of disease.
From total sum of 170 asthmatic patients the software
correctly classified 149 patients after IOS and spirometry
test results, 17 patients after BDT results, 4 patients
after BPT results, while incorrectly classified 1 patient
after BDT results.
From total sum of 248 COPD patients the software
correctly classified 212 patients after IOS and spirometry
test results, 34 patients after BDT results, while incor-
rectly classified 2 patients after BDT results.
It also may be noted that the software classified
majority of the patients (over 85%) instantly upon the
completion of standard tests (spirometry and IOS), with-
out a single failure.
Full confusion matrix for performance of implemented
algorithm is presented in table 5.
The best and final results are achieved only after com-
pleting the entire process of classification of disease, i.e.
after obtaining a complete dynamic assessment of the
patient.
Discussion
When making diagnosis of a respiratory disease, physi-
cians use results obtained from spirometry and IOS.
These results show that there is a correlation between
parameters obtained by spirometry and IOS. In 2011,
the Mehdi Nikkhah et al [35] compared methods of
spirometry and IOS measurements in diagnosis of
asthma and COPD patients. Furthermore, they demon-
strated a correlation between IOS parameters and FEV1
parameter in asthmatics. They had shown that only R5
had a correlation with FEV1 in COPD patients, and that
the progress of COPD disease is closely associated with
the R5 parameter. Also, they had shown that in the case
of their subjects sensitivity of X5 parameter in COPD
patients is 76%, whereas in asthmatics sensitivity of R20
is 77%. In their studies, Kolsum et al in 2008 [36] and
Song et al in 2009 [38] had already shown the correla-
tion between R5 and X5 with FEV1. Since studies have
shown that the combination of spirometry and IOS
measurements achieve more successful diagnosis, the
method which we developed for classification of asthma
and COPD is using both type of measurements.
In 2009, Winkler et al [15] were able to diagnose 87-94%
of asthma and COPD patients only when using different
measurement methods on IOS. The same year Chakra-
borty et al [39] presented an intelligent diagnostic system
for bronchial asthma based on symptoms and questions to
which patients responded and obtained 90.03% accuracy
in diagnosing asthma. In 2004, M. Barua et al [14]
presented a system based on trained neural networks that
uses the results of measurements performed by IOS for
classification of asthma. They tested the system on 131
patients and obtained a 98% exact classification with
known patterns, while their neural network, when working
with unknown patterns, confirmed exact classification in
61% of cases. In our study, from a total sum of first time
entered patients, after using only standard tests, the cor-
rect classification of patients was achieved in 87.65% of
cases of asthma and 85.50% of COPD. If we use BDT and/
or BPT suggested by neuro-fuzzy system, then we achieve
correct classification in 99.41% of cases of asthma and
99.19% of COPD patients.
In 2006, Price D.B. et al [40] developed a tool in the
form of a quiz based on the questions in order to recog-
nize COPD in smokers and suggested further testing,
while in the same year Tinkelman DG et al [41] further
expanded their diagnostic tool for asthma and COPD.
They tested it on 597 patients and obtained a sensitivity of
72.0% and specificity of 82.7%. While testing developed
neuro-fuzzy system on our 455 study patients, we obtained
sensitivity of 99.28% and specificity of 100%.
Tinkelman DG et al also presented the degrees in
which the diagnosis of asthma and COPD are usually
established, in the same way as presented in Figure 3 of
our study.
In 2008, E. Meraz et al [17] and in 2009 N. Hafezi
et al [18], based on known equivalent electrical models
of lungs and their values specified for the healthy and
diseased patients [42-49], developed a computational
tool that classifies respiratory diseases in children by
Table 3 Comparison between Feed Forward and Layer
Recurrent ANN.










Table 4 Effectiveness of the neuro-fuzzy system in
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using IOS results. The advantage of our previous
research [50-52] and new solution with respect to the
one presented by E. Meraz et al [17] and N. Hafezi et al
[18] is that our solution uses a combination of spirome-
try and IOS classification test results, which in the very
beginning enables more accurate classification. Also, for
the classification of diseases, in addition to the results
obtained by using spirometry and IOS, symptoms
according to GINA and GOLD rules as well as bronch-
iodilatory tests are necessary for proper classification of
asthma and COPD. In this way, we get a complete
patient’s dynamic assessment, as opposed to the solution
that provides a static assessment of the patient. The
solution presented by Meraz [17] and Hafezi [18] is
based on the equivalent electrical models of lungs, and
those values are obtained from previous studies where
age and race of the patients have to be taken into
account, which is not the case in our solution.
In 2007, G. Coppin et al [53] introduced a computer sys-
tem based on neural networks that detects emphysema
using digital x-rays performed on patients with COPD,
where they had accuracy of 90% on 161 subjects. This can
be a great tool in combination with neuro-fuzzy system
presented in our study.
Figure 3 Hits and misses of neuro-fuzzy system at each single step of classification in asthmatics and COPD patients.
Table 5 Confusion matrix for performance of implemented algorithm.
Total population
455
Condition positive Condition negative Prevalence
91.64%
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In the future work, the aim of the researchers is to
develop rules of fuzzy logic and neural network training
for other respiratory diseases that can be determined on
the basis of lung function tests.
Conclusions
In this study we presented a neuro-fuzzy system for clas-
sification of asthma and chronic obstructive pulmonary
disease (COPD). According to GINA and GOLD guide-
lines we defined fuzzy rules and neural network para-
meters. ANN of system was trained on more than one
thousand medical reports obtained from database of the
company CareFusion. Implemented neuro-fuzzy system
was validated on 455 patients by physicians from the
Clinical Centre University of Sarajevo. All patients were
separated into two groups, healthy and diseased. Diseased
subjects were separated into two subgroups, asthmatics
and COPD patients. Out of 170 asthmatic patients,
neuro-fuzzy system correctly classified 99.41% of
patients. In addition, out of 248 COPD patients 99.19%
were correctly classified. The system was 100% correct
on 37 patients with normal lung function. Based on our
neuro-fuzzy system we obtained sensitivity of 99.28% and
specificity of 100% in asthma and COPD classification.
These results have been achieved due to the fact that in
our neuro-fuzzy system are also implemented all recom-
mendations of GINA and GOLD necessary for classifica-
tion of asthma and COPD. Also, as shown in the results,
in the process of establishing the final diagnosis, com-
plete dynamic assessment of the patient is obtained, as
opposed to the solution that provides a static assessment
of the patient.
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